2-178604170-G-A
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001267550.2(TTN):c.54517C>T(p.Pro18173Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,612,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P18173Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | MANE Select | c.54517C>T | p.Pro18173Ser | missense | Exon 282 of 363 | NP_001254479.2 | ||
| TTN | NM_001256850.1 | c.49594C>T | p.Pro16532Ser | missense | Exon 232 of 313 | NP_001243779.1 | |||
| TTN | NM_133378.4 | c.46813C>T | p.Pro15605Ser | missense | Exon 231 of 312 | NP_596869.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | TSL:5 MANE Select | c.54517C>T | p.Pro18173Ser | missense | Exon 282 of 363 | ENSP00000467141.1 | ||
| TTN | ENST00000446966.2 | TSL:1 | c.54361C>T | p.Pro18121Ser | missense | Exon 280 of 361 | ENSP00000408004.2 | ||
| TTN | ENST00000436599.2 | TSL:1 | c.54241C>T | p.Pro18081Ser | missense | Exon 280 of 361 | ENSP00000405517.2 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151914Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000262 AC: 65AN: 247662 AF XY: 0.000208 show subpopulations
GnomAD4 exome AF: 0.0000459 AC: 67AN: 1460094Hom.: 0 Cov.: 31 AF XY: 0.0000386 AC XY: 28AN XY: 726326 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151914Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74158 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Pro15605Ser v ariant in TTN has been identified by our laboratory in one individual with infan tile onset of LV dysfunction and in 0.2% (64/34306) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP r s766074604). Computational prediction tools and conservation analysis suggest th at this variant may impact the protein, though this information is not predictiv e enough to determine pathogenicity. In summary, while the clinical significance of the p.Pro15605Ser variant is uncertain, its frequency suggests that it is mo re likely to be benign.
not provided Uncertain:1
TTN-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Cardiomyopathy Benign:1
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at